Last update Nov. 24, 2014

Maternal Hyperprolactinemia

Low Risk

Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Hyperprolactinemia by itself is not a contraindication while breastfeeding. There is experience about long-lasting breastfeeding from 8 to 33 months long without encountering any problem (even when patients have taken Bromocriptine).

If because an increased level of prolactinemia it would require medication, it is preferred to use Bromocriptine or Lisuride instead of Cabergoline because a lesser storage in blood, lesser passage to breast milk and poor absorption by the infant, even though, they are worst tolerated by the mother.

Alternatives

We do not have alternatives for Maternal Hyperprolactinemia.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Maternal Hyperprolactinemia is also known as


Group

Maternal Hyperprolactinemia belongs to this group or family:

References

  1. Serrano Aguayo P, García de Quirós Muñoz JM, Bretón Lesmes I, Cózar León MV. Tratamiento de enfermedades endocrinológicas durante la lactancia. [Endocrinologic diseases management during breastfeeding.] Med Clin (Barc). 2015 Jan 20;144(2):73-9. Abstract
  2. Domingue ME, Devuyst F, Alexopoulou O, Corvilain B, Maiter D. Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients. Clin Endocrinol (Oxf). 2014 Abstract
  3. Auriemma RS, Perone Y, Di Sarno A, Grasso LF, Guerra E, Gasperi M, Pivonello R, Colao A. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab. 2013 Abstract Full text (link to original source) Full text (in our servers)
  4. Shahzad H, Sheikh A, Sheikh L. Cabergoline therapy for macroprolactinoma during pregnancy: a case report. BMC Res Notes. 2012 Abstract Full text (link to original source) Full text (in our servers)
  5. Verma S, Shah D, Faridi MM. Breastfeeding a baby with mother on Bromocripine. Indian J Pediatr. 2006 Abstract

Total visits

9,897

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM